Pancreatitis aguda

Referencias

Artículos principales

Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep;108(9):1400-15. Resumen

Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019 Jun 13;14:27.Texto completo  Resumen

Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15.Texto completo  Resumen

American College of Radiology. ACR appropriateness criteria: acute pancreatitis. 2019 [internet publication].Texto completo

Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018 Mar;154(4):1096-101. Resumen

Artículos de referencia

1. Nirula R. Chapter 9: Diseases of the pancreas. High yield surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.

2. Banks PA, Bollen TL, Dervenis C, et al; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11.Texto completo  Resumen

3. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990 Feb;174(2):331-6. Resumen

4. Doherty GM, Meko JB, Olson JA, et al. Chapter 17: Pancreas. In: The Washington manual of surgery. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.

5. Way LW, Doherty GM. Chapter 27: Pancreas. In: Current surgical diagnosis & treatment. 11th ed. New York, NY: McGraw-Hill; 2003.

6. Raghu MG, Wig JD, Kochhar R, et al. Lung complications in acute pancreatitis. JOP. 2007 Mar 10;8(2):177-85. Resumen

7. Kingsnorth A, O'Reilly D. Acute pancreatitis. BMJ. 2006 May 6;332(7549):1072-6.Texto completo  Resumen

8. Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016 Sep;1(1):45-55. Resumen

9. GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-47.Texto completo  Resumen

10. Munoz A, Katerndahl DA. Diagnosis and management of acute pancreatitis. Am Fam Physician. 2000 Jul 1;62(1):164-74.Texto completo  Resumen

11. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019 Jan;156(1):254-72.e11.Texto completo  Resumen

12. Brindise E, Elkhatib I, Kuruvilla A, et al. Temporal trends in incidence and outcomes of acute pancreatitis in hospitalized patients in the United States from 2002 to 2013. Pancreas. 2019 Feb;48(2):169-75. Resumen

13. Whitcomb DC. Clinical practice: acute pancreatitis. N Engl J Med. 2006 May 18;354(20):2142-50. Resumen

14. Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021 Jan 26;325(4):382-90. Resumen

15. Roberts SE, Morrison-Rees S, John A, et al. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017 Mar - Apr;17(2):155-65. Resumen

16. van Brummelen SE, Venneman NG, van Erpecum KJ, et al. Acute idiopathic pancreatitis: does it really exist or is it a myth? Scand J Gastroenterol Suppl. 2003;(239):117-22. Resumen

17. Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep;108(9):1400-15. Resumen

18. Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019 Dec 2;367:l6227. Resumen

19. Brunicardi FC, Andersen DK, Billiar TR. Chapter 32: Pancreas. In: Schwartz's principles of surgery. 8th ed. New York, NY: McGraw-Hill; 2005.

20. Underwood TW, Frye CB. Drug-induced pancreatitis. Clin Pharm. 1993 Jun;12(6):440-8. Resumen

21. Gelrud A, Sheth S, Banerjee S, et al. Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol. 2004 Aug;99(8):1557-62. Resumen

22. Maxson CJ, Greenfield SM, Turner JL. Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992 Jun;87(6):708-13. Resumen

23. Tenner S. Drug induced acute pancreatitis: does it exist? World J Gastroenterol. 2014 Nov 28;20(44):16529-34.Texto completo  Resumen

24. Sah RP, Saluja A. Molecular mechanisms of pancreatic injury. Curr Opin Gastroenterol. 2011 Sep;27(5):444-51.Texto completo  Resumen

25. Townsend C. Chapter 53: exocrine pancreas. In: Sabiston textbook of surgery board review. 17th ed. Philadelphia, PA: Saunders; 2004.

26. Carr RA, Rejowski BJ, Cote G2, et al. Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology? Pancreatology. 2016 Jul-Aug;16(4):469-76. Resumen

27. Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019 Jun 13;14:27.Texto completo  Resumen

28. Bálint ER, Fűr G, Kiss L, et al. Assessment of the course of acute pancreatitis in the light of aetiology: a systematic review and meta-analysis. Sci Rep. 2020 Oct 21;10(1):17936.Texto completo  Resumen

29. Frick TW, Wiegand D, Bimmler D, et al. A rat model to study hypercalcemia-induced acute pancreatitis. Int J Pancreatol. 1994 Apr;15(2):91-6. Resumen

30. Frick TW, Spycher MA, Heitz PU, et al. Hypercalcaemia and pancreatic ultrastructure in cats. Eur J Surg. 1992 May;158(5):289-94. Resumen

31. Juang P, Page RL, Zolty R. Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient. Ann Pharmacother. 2006 Jan;40(1):128-34. Resumen

32. Akshintala VS, Sperna Weiland CJ, Bhullar FA, et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021 Sep;6(9):733-42. Resumen

33. Akbar A, Abu Dayyeh BK, Baron TH, et al. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol. 2013 Jul;11(7):778-83. Resumen

34. Yaghoobi M, Rolland S, Waschke KA, et al. Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013 Nov;38(9):995-1001.Texto completo  Resumen

35. Elmunzer BJ, Higgins PD, Saini SD, et al; United States Cooperative for Outcomes Research in Endoscopy. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013 Mar;108(3):410-5.Texto completo  Resumen

36. Márta K, Gede N, Szakács Z, et al. Combined use of indomethacin and hydration is the best conservative approach for post-ERCP pancreatitis prevention: a network meta-analysis. Pancreatology. 2021 Oct;21(7):1247-55.Texto completo  Resumen

37. Buxbaum J, Yan A, Yeh K, et al. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014 Feb;12(2):303-7.e1.Texto completo  Resumen

38. Wu D, Wan J, Xia L, et al. The efficiency of aggressive hydration with lactated ringer solution for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. J Clin Gastroenterol. 2017 Sep;51(8):e68-76. Resumen

39. Zhang ZF, Duan ZJ, Wang LX, et al. Aggressive hydration with lactated Ringer solution in prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2017 Mar;51(3):e17-26. Resumen

40. Singh P, Das A, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc. 2004 Oct;60(4):544-50. Resumen

41. Heyries L, Barthet M, Delvasto C, et al. Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis. Gastrointest Endosc. 2002 Mar;55(3):376-81. Resumen

42. Spicak J. Etiological factors of acute pancreatitis [in Czech]. Vnitr Lek. 2002 Sep;48(9):829-41. Resumen

43. Guda NM, Muddana V, Whitcomb DC, et al. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas. 2018 Jul;47(6):653-66. Resumen

44. Vitone LJ, Greenhalf W, Howes NR, et al. Hereditary pancreatitis and secondary screening for early pancreatic cancer. Rocz Akad Med Bialymst. 2005;50:73-84. Resumen

45. Whitcomb DC. Genetic risk factors for pancreatic disorders. Gastroenterology. 2013 Jun;144(6):1292-302.Texto completo  Resumen

46. Whitcomb DC. Genetic aspects of pancreatitis. Annu Rev Med. 2010;61:413-24. Resumen

47. Giefer MJ, Lowe ME, Werlin SL, et al. Early-onset acute recurrent and chronic pancreatitis is associated with PRSS1 or CTRC gene mutations. J Pediatr. 2017 Jul;186:95-100.Texto completo  Resumen

48. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15.Texto completo  Resumen

49. National Institute for Health and Care Excellence. Pancreatitis. Dec 2020 [internet publication].Texto completo

50. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003 Apr;31(4):1250-6. Resumen

51. Bass G, Gilani SN, Walsh TN. Validating the 5Fs mnemonic for cholelithiasis: time to include family history. Postgrad Med J. 2013 Nov;89(1057):638-41. Resumen

52. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012 Apr;6(2):172-87.Texto completo  Resumen

53. Zuo L, Wang CH, Yang JL, et al. The role of a workflow in diagnosing biliary causes for acute pancreatitis [in Chinese]. Zhonghua Nei Ke Za Zhi. 2012 Feb;51(2):104-7. Resumen

54. Hujoel IA. The association between serum calcium levels and Chvostek sign: a population-based study. Neurol Clin Pract. 2016 Aug;6(4):321-8.Texto completo  Resumen

55. Rompianesi G, Hann A, Komolafe O, et al. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017 Apr 21;(4):CD012010.Texto completo  Resumen

56. Choosing Wisely. American Society for Clinical Pathology: testing for amylase. Sep 2016 [internet publication].Texto completo

57. Steinberg WM, Nauck MA, Zinman B, et al. LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. Pancreas. 2014 Nov;43(8):1223-31.Texto completo  Resumen

58. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas. 2000 May;20(4):367-72. Resumen

59. Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol. 1994 Oct;89(10):1863-6. Resumen

60. Khanna AK, Meher S, Prakash S, et al. Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis. HPB Surg. 2013;2013:367581.Texto completo  Resumen

61. Komolafe O, Pereira SP, Davidson BR, et al. Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis. Cochrane Database Syst Rev. 2017 Apr 21;(4):CD012645.Texto completo  Resumen

62. Ranson JH, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet. 1976 Aug;143(2):209-19. Resumen

63. American College of Radiology. ACR appropriateness criteria: acute pancreatitis. 2019 [internet publication].Texto completo

64. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008 Jan 12;371(9607):143-52. Resumen

65. Fogel EL, Sherman S. ERCP for gallstone pancreatitis. N Engl J Med. 2014 Jan 9;370(2):150-7. Resumen

66. ASGE Standards of Practice Committee; Muthusamy VR, Chandrasekhara V, Acosta RD, et al. The role of endoscopy in the diagnosis and treatment of inflammatory pancreatic fluid collections. Gastrointest Endosc. 2016 Mar;83(3):481-8.Texto completo  Resumen

67. McPherson RA, Pincus MR. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia, PA: Saunders; 2006.

68. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644-55. Resumen

69. Baillie J, ed. Advances in endoscopy: current developments in diagnostic and therapeutic endoscopy. Gastroenterol Hepatol (N Y). 2010 Jan;6(1):16-8.Texto completo  Resumen

70. Darvas K, Futo J, Okros I, et al. Principles of intensive care in severe acute pancreatitis in 2008 [in Hungarian]. Orv Hetil. 2008 Nov 23;149(47):2211-20. Resumen

71. Curtis CS, Kudsk KA. Nutrition support in pancreatitis. Surg Clin North Am. 2007 Dec;87(6):1403-15. Resumen

72. Thomson A. Nutritional support in acute pancreatitis. Curr Opin Clin Nutr Metab Care. 2008 May;11(3):261-6. Resumen

73. Marik PE. What is the best way to feed patients with pancreatitis? Curr Opin Crit Care. 2009 Apr;15(2):131-8. Resumen

74. Choosakul S, Harinwan K, Chirapongsathorn S, et al. Comparison of normal saline versus Lactated Ringer's solution for fluid resuscitation in patients with mild acute pancreatitis, a randomized controlled trial. Pancreatology. 2018 Jul;18(5):507-12. Resumen

75. Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018 Mar 1;378(9):829-39.Texto completo  Resumen

76. Zampieri FG, Machado FR, Biondi RS, et al. Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA. 2021 Aug 10;326(9):1-12.Texto completo  Resumen

77. Finfer S, Micallef S, Hammond N, et al. Balanced multielectrolyte solution versus saline in critically ill adults. N Engl J Med. 2022 Jan 18 [Epub ahead of print]. Resumen

78. Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018 Mar;154(4):1096-101. Resumen

79. Buxbaum JL, Quezada M, Da B, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol. 2017 May;112(5):797-803. Resumen

80. Fisher JM, Gardner TB. The "golden hours" of management in acute pancreatitis. Am J Gastroenterol. 2012 Aug;107(8):1146-50. Resumen

81. van Dijk SM, Hallensleben NDL, van Santvoort HC, et al. Acute pancreatitis: recent advances through randomised trials. Gut. 2017 Nov;66(11):2024-32. Resumen

82. Moretti A, Papi C, Aratari A, et al. Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of randomized controlled trials. Dig Liver Dis. 2008 May;40(5):379-85. Resumen

83. Basurto Ona X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013 Jul 26;(7):CD009179.Texto completo  Resumen

84. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012 Apr;60(4):616-31.Texto completo  Resumen

85. Ramírez-Maldonado E, López Gordo S, Pueyo EM, et al. Immediate oral refeeding in patients with mild and moderate acute pancreatitis: a multicenter, randomized controlled trial (PADI trial). Ann Surg. 2021 Aug 1;274(2):255-63. Resumen

86. Vaughn VM, Shuster D, Rogers MAM, et al. Early versus delayed feeding in patients with acute pancreatitis: a systematic review. Ann Intern Med. 2017 Jun 20;166(12):883-92. Resumen

87. Bakker OJ, van Brunschot S, van Santvoort HC, et al. Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med. 2014 Nov 20;371(21):1983-93.Texto completo  Resumen

88. Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020 Mar;39(3):612-31.Texto completo  Resumen

89. Yi F, Ge L, Zhao J, et al. Meta-analysis: total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis. Intern Med. 2012;51(6):523-30.Texto completo  Resumen

90. Mirtallo JM, Forbes A, McClave SA, et al. International consensus guidelines for nutrition therapy in pancreatitis. JPEN J Parenter Enteral Nutr. 2012 May;36(3):284-91. Resumen

91. Petrov MS, Zagainov V. Influence of enteral versus parenteral nutrition on blood glucose control in acute pancreatitis: a systematic review. Clin Nutr. 2007 Oct;26(5):514-23. Resumen

92. Petrov MS, Kukosh MV, Emelyanov NV. A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition. Dig Surg. 2006;23(5-6):336-44; discussion 344-5. Resumen

93. Dutta AK, Goel A, Kirubakaran R, et al. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis. Cochrane Database Syst Rev. 2020 Mar 26;(3):CD010582.Texto completo  Resumen

94. Poropat G, Giljaca V, Hauser G, et al. Enteral nutrition formulations for acute pancreatitis. Cochrane Database Syst Rev. 2015 Mar 23;(3):CD010605.Texto completo  Resumen

95. Meier R, Beglinger C, Layer P, et al; European Society of Parenteral and Enteral Nutrition. ESPEN guidelines on nutrition in acute pancreatitis. Clin Nutr. 2002 Apr;21(2):173-83. Resumen

96. Gianotti L, Meier R, Lobo DN, et al; ESPEN. ESPEN guidelines on parenteral nutrition: pancreas. Clin Nutr. 2009 Aug;28(4):428-35. Resumen

97. Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007 May;245(5):674-83.Texto completo  Resumen

98. Jiang K, Huang W, Yang XN, et al. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol. 2012 Jan 21;18(3):279-84.Texto completo  Resumen

99. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Mar 2019 [internet publication].Texto completo

100. US Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Jul 2018 [internet publication].Texto completo

101. US Food and Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].Texto completo

102. Boxhoorn L, van Dijk SM, van Grinsven J, et al. Immediate versus postponed intervention for infected necrotizing pancreatitis. N Engl J Med. 2021 Oct 7;385(15):1372-81. Resumen

103. Gurusamy KS, Belgaumkar AP, Haswell A, et al. Interventions for necrotising pancreatitis. Cochrane Database Syst Rev. 2016 Apr 16;(4):CD011383.Texto completo  Resumen

104. Gluck M, Ross A, Irani S, et al. Endoscopic and percutaneous drainage of symptomatic walled-off pancreatic necrosis reduces hospital stay and radiographic resources. Clin Gastroenterol Hepatol. 2010 Dec;8(12):1083-8.Texto completo  Resumen

105. Vitas GJ, Sarr MG. Selected management of pancreatic pseudocysts: operative versus expectant management. Surgery. 1992 Feb;111(2):123-30. Resumen

106. Sankaran SJ, Xiao AY, Wu LM, et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology. 2015 Nov;149(6):1490-500.Texto completo  Resumen

107. Herrera ME, Seller G, de la Rubia C, et al. Hemofiltration in acute pancreatitis [in Spanish]. Med Intensiva. 2003;27:137-43.

108. Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet. 1995 Sep 9;346(8976):663-7. Resumen

109. Hernandez-Aranda JC, Gallo-Chico B, Ramirez-Barba EJ. Nutritional support in severe acute pancreatitis. Controlled clinical trial [in Spanish]. Nutr Hosp. 1996 May-Jun;11(3):160-6. Resumen

110. Kotani J, Usami M, Nomura H, et al. Enteral nutrition prevents bacterial translocation but does not improve survival during acute pancreatitis. Arch Surg. 1999 Mar;134(3):287-92. Resumen

111. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas. 2003 Mar;26(2):122-9. Resumen

112. Hart PA, Bradley D, Conwell DL, et al. Diabetes following acute pancreatitis. Lancet Gastroenterol Hepatol. 2021 Aug;6(8):668-75. Resumen

113. Bråthen G, Ben-Menachem E, Brodtkorb E, et al. Chapter 29: alcohol-related seizures. EFNS guidelines of alcohol-related seizures. In: Gilhus NE, Barnes MP, Brainin M, eds. European handbook of neurological management. 2nd ed, v1. Oxford, UK: Blackwell Publishing; 2011:429-36.

114. Preiss D, Tikkanen MJ, Welsh P, et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012 Aug 22;308(8):804-11.Texto completo  Resumen

115. Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc. 2000 Jan;51(1):1-7. Resumen

116. Venneman NG, van Erpecum KJ. Gallstone disease: primary and secondary prevention. Best Pract Res Clin Gastroenterol. 2006;20(6):1063-73. Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad